Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Gary McAdam
AddedMar 31, 2024
UpdatedMay 31, 2026
Gary McAdam

Gary McAdam

Co-Founder, NeuroX Innovations

Crunchbase

Gary McAdam's Career

NeuroX Innovations
NeuroX Innovations

Fort Collins, CO, US

Co-Founder
Early Detection
Early Detection

San Diego, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Gary McAdam's Career

NeuroX Innovations
NeuroX Innovations
Seed$575k72022Fort Collins, CO, US
Co-Founder

Leadership at NeuroX Innovations

Scott FardulisScott FardulisCo-Founder
Jordan DolesJordan DolesCo-Founder
Jim FasoneJim FasoneCo-Founder

Similar to NeuroX Innovations

Phantom NeuroPhantom NeuroAustin, TX, USExoskeletons, Prostheticsest. 2020Phantom NeuroAustin, TX, US · est. 2020

Phantom Neuro: Engineering lifelike control for robotic orthopedic technologies.

Seed · $9.3M7
NeuroBionicsNeuroBionicsSeattle, WA, USMedical DevicesNeuroBionicsSeattle, WA, US

Developing medical devices for neurological disorders.

Series A · $6M6
NeurolutionsNeurolutionsSt. Louis, MO, USMedical Devicesest. 2007NeurolutionsSt. Louis, MO, US · est. 2007

Neurolutions, Inc.: Innovating thought-controlled devices for neurological injury recovery.

Pre-Seed · $1.3M10
Neuro-KinesisNeuro-KinesisInglewood, CA, USSurgical Toolsest. 2013Neuro-KinesisInglewood, CA, US · est. 2013

Neuro-Kinesis, a medical tech firm, innovates surgical tools with advanced biosensors for real-time biofeedback, enhancing patient outcomes.

Seed · $50k6
Early Detection
Early Detection
Seed$282k72017San Diego, CA, US
Co-Founder

Leadership at Early Detection

Kim VanderlindenKim VanderlindenCo-Founder
abulkalam shamsuddinabulkalam shamsuddinCo-Founder

Similar to Early Detection

Thrive Earlier DetectionThrive Earlier DetectionCambridge, MA, USCancer Detectionest. 2019Thrive Earlier DetectionCambridge, MA, US · est. 2019

Thrive, a healthcare company, pioneers in early cancer detection through its innovative test, CancerSEEK.

Late Stage Private · $367M175
OncodeaOncodeaSaint Paul, MN, USCancer Detectionest. 2021OncodeaSaint Paul, MN, US · est. 2021

Oncodea: Pioneering affordable, non-invasive cancer detection technology since 2021.

Angel · $6k7
Exact SciencesExact SciencesMadison, WI, USCancer Diagnosticsest. 1995Exact SciencesMadison, WI, US · est. 1995

Exact Sciences Corp., a US-based firm, develops non-invasive tests for early colorectal cancer detection.

Public · $2.1B6.4k
Early is GoodEarly is GoodIndianapolis, IN, USMedical Diagnosticsest. 2020Early is GoodIndianapolis, IN, US · est. 2020

Early is Good, an Indianapolis-based medical firm, specializes in early, accurate detection of renal diseases.

Seed · $5.5M5

People Similar to Gary McAdam

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · KakaoNickolas PapadopoulosNickolas PapadopoulosCo-Founder · Thrive Earlier DetectionBert VogelsteinBert VogelsteinCo-Founder · Thrive Earlier DetectionKenneth KinzlerKenneth KinzlerCo-Founder · Thrive Earlier DetectionIan WilliamsIan WilliamsCo-Founder · Life Detection TechnologiesJohn LangleyJohn LangleyCo-Founder · Life Detection TechnologiesMichael BardashMichael BardashCo-Founder · Radiation Detection Solutions